Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James T Boyd

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Parkinson'S Disease|February 28, 2020
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of LevodopaCindy Zadikoff, Werner Poewe, James T Boyd, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2016
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patientsAngelo Antonini, Victor S C Fung, James T Boyd, et al.
Journal of the Neurological Sciences|June 12, 2016
Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North AmericaJohn L Goudreau, Adriana Pérez, Michael J Aminoff, et al.
Journal of Parkinson'S Disease|October 15, 2014
Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating ScaleSotirios A Parashos, Jordan Elm, James T Boyd, et al.
Parkinsonism & Related Disorders|January 31, 2026
Parkinson's disease with and without history of Agent Orange exposure: A prospective study of US VeteransVivikta Iyer, Cole Zweber, Ian Zurlo, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
CDS-PD: A Novel Clinical Decision Support Platform for Parkinson's DiseaseDeepak K Gupta, Pedram Golnari, Katrina Prantzalos, et al.
Scientific Reports|January 27, 2026
CDS-PD: a novel clinical decision support platform for Parkinson's diseaseDeepak K Gupta, Pedram Golnari, Katrina Prantzalos, et al.
Parkinsonism & Related Disorders|December 27, 2014
Parkinson's disease severity and use of dopaminergic medicationsJohn Y Fang, Adriana Pérez, Chadwick W Christine, et al.
NEJM Evidence|February 6, 2024
Transdermal Nicotine Treatment and Progression of Early Parkinson's DiseaseWolfgang H Oertel, Hans-Helge Müller, Marcus M Unger, et al.
Neurology|October 4, 2017
Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scoresMaureen Leehey, Sheng Luo, Saloni Sharma, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Parkinson'S Disease|February 28, 2020
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of LevodopaCindy Zadikoff, Werner Poewe, James T Boyd, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2016
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patientsAngelo Antonini, Victor S C Fung, James T Boyd, et al.
Journal of the Neurological Sciences|June 12, 2016
Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North AmericaJohn L Goudreau, Adriana Pérez, Michael J Aminoff, et al.
Journal of Parkinson'S Disease|October 15, 2014
Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating ScaleSotirios A Parashos, Jordan Elm, James T Boyd, et al.
Parkinsonism & Related Disorders|January 31, 2026
Parkinson's disease with and without history of Agent Orange exposure: A prospective study of US VeteransVivikta Iyer, Cole Zweber, Ian Zurlo, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
CDS-PD: A Novel Clinical Decision Support Platform for Parkinson's DiseaseDeepak K Gupta, Pedram Golnari, Katrina Prantzalos, et al.
Scientific Reports|January 27, 2026
CDS-PD: a novel clinical decision support platform for Parkinson's diseaseDeepak K Gupta, Pedram Golnari, Katrina Prantzalos, et al.
Parkinsonism & Related Disorders|December 27, 2014
Parkinson's disease severity and use of dopaminergic medicationsJohn Y Fang, Adriana Pérez, Chadwick W Christine, et al.
NEJM Evidence|February 6, 2024
Transdermal Nicotine Treatment and Progression of Early Parkinson's DiseaseWolfgang H Oertel, Hans-Helge Müller, Marcus M Unger, et al.
Neurology|October 4, 2017
Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scoresMaureen Leehey, Sheng Luo, Saloni Sharma, et al.
Pageof 3